FIXIWEL-CV contains Cefixime 200 mg + Potassium Clavulanate 125 mg, designed to provide enhanced antibacterial coverage against susceptible organisms producing certain beta-lactamases. A differentiated PCD Pharma antibiotic offering.
To inhibit certain beta-lactamases and extend antibacterial coverage.
No.
Use strictly as prescribed and complete the course. Inform the physician about penicillin/cephalosporin allergy, liver problems or previous antibiotic-related diarrhea.
Diarrhea, nausea, vomiting, abdominal discomfort, headache and rash may occur.
FIXIWEL-CV: Cefixime inhibits bacterial cell-wall synthesis, while Clavulanate inhibits beta-lactamases produced by certain bacteria, helping protect Cefixime from enzymatic inactivation.
